These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34414335)

  • 21. Colchicine for cardiovascular medicine: a systematic review and meta-analysis.
    Casula M; Andreis A; Avondo S; Vaira MP; Imazio M
    Future Cardiol; 2022 Aug; 18(8):647-659. PubMed ID: 35787150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Updated Meta-Analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease.
    Katsanos AH; Palaiodimou L; Price C; Themistocleous M; Lemmens R; Michopoulos I; Georgakis MK; Weimar C; Kelly P; Tsivgoulis G
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials.
    Teo YN; Teo YH; Syn NL; Goh MW; Yoong CSY; Lee CH; Chan MY; Chai P; Yeo TC; Sia CH
    High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):343-354. PubMed ID: 34003455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: a systematic review and meta-analysis.
    Zhou Y; Liu Y; Zeng R; Qiu W; Zhao Y; Zhou Y
    Front Cardiovasc Med; 2023; 10():1194605. PubMed ID: 37608812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine efficacy and safety for the treatment of cardiovascular diseases.
    Andreis A; Imazio M; Casula M; Avondo S; De Ferrari GM
    Intern Emerg Med; 2021 Sep; 16(6):1691-1700. PubMed ID: 33704674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic therapy for pelvic inflammatory disease.
    Savaris RF; Fuhrich DG; Duarte RV; Franik S; Ross J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010285. PubMed ID: 28436019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis.
    Xiang Z; Yang J; Yang J; Zhang J; Fan Z; Yang C; Di L; Ma C; Wu J; Huang Y
    Intern Emerg Med; 2021 Mar; 16(2):487-496. PubMed ID: 33400158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.
    Li W; He W; Zhou Y; Guo Y
    PLoS One; 2020; 15(7):e0234655. PubMed ID: 32614851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine for the prevention of ischemic stroke: An updated meta-analysis of randomized clinical trials.
    Al-Atta A; Kuzemczak M; Alkhalil M
    Brain Circ; 2021; 7(3):187-193. PubMed ID: 34667902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colchicine for Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chunfeng L; Ping L; Yun Z; Di L; Qi W
    Heart Surg Forum; 2021 Oct; 24(5):E863-E867. PubMed ID: 34623257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials.
    Sethuramalingam S; Maiti R; Hota D; Srinivasan A
    Am J Ther; 2023 May; 30(3):e197-e208. PubMed ID: 34264887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
    Bytyçi I; Bajraktari G; Penson PE; Henein MY; Banach M; ;
    Br J Clin Pharmacol; 2022 Feb; 88(4):1520-1528. PubMed ID: 34409634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease.
    Grajek S; Michalak M; Urbanowicz T; Olasińska-Wiśniewska A
    Front Cardiovasc Med; 2021; 8():740896. PubMed ID: 34957237
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluating the Utility of Colchicine in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
    Bao YL; Gu LF; Du C; Wang YX; Wang LS
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):639-647. PubMed ID: 35881909
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.